Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov;5(7):944-953.
doi: 10.1177/2050640617705576. Epub 2017 May 8.

The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma

Affiliations
Review

The gut microbiota: A new potential driving force in liver cirrhosis and hepatocellular carcinoma

Marco Sanduzzi Zamparelli et al. United European Gastroenterol J. 2017 Nov.

Abstract

The gut microbiota has recently been recognized as a major environmental factor in the pathophysiology of many human diseases. The anatomical and function connection existing between gut and liver provides the theoretical basis to assume the liver is a major target for gut microbes. In the last decades, numerous studies reported an altered composition of gut microbiota in patients with liver cirrhosis and a progressively marked dysbiosis with worsening of the liver disease. The risk of developing hepatocellular carcinoma, the deadliest complication of liver cirrhosis, is widely variable among cirrhotic patients, thus suggesting a complexity of genetic and environmental factors implicated in hepatocarcinogenesis. Gut microbiota is now emerging as a plausible candidate to explain this variability. In this manuscript we review the human and the experimental evidence supporting the potential implication of gut microbiota in the promotion, progression and complication of liver disease.

Keywords: Gut bacteria; bacterial translocation; dysbiosis; liver carcinogenesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol 2014; 28: 753–770. - PubMed
    1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907–1917. - PubMed
    1. Kåhrström CT, Pariente N, Weiss U. Intestinal microbiota in health and disease. Nature 2016; 535: 47–47. - PubMed
    1. Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut 2016; 65: 2035–2044. - PubMed
    1. Tabibian JH, Varghese C, LaRusso NF, et al. The enteric microbiome in hepatobiliary health and disease. Liver Int 2016; 36: 480–487. - PMC - PubMed